secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-12-26T23:59:59+00:00
Accession:  0001104659-24-131723
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics announces $5M convertible note and $50M standby equity facility
--------------------------------------------------------------------------------

- Entered $5M convertible promissory note with Yorkville, 13-month term, 7% original issue discount, no interest.
- Conversion at small discount to market price; limited to 1/6 of note per month unless conversion price above $0.315.
- Standby equity subscription agreement allows company to require Yorkville to buy up to $50M of common shares after note repaid/converted.
- Standby facility has 24-month term; no obligation to draw; company can cancel anytime after note repaid/converted.
- Proceeds for general corporate purposes; Joseph Gunnar & Co. acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924131723/0001104659-24-131723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924131723/tm2432020d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-131723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer